Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease

Table 1 Clinical characteristics of patients with liver steatosis

Clinical characteristic	Grade of steatosis (% of steatosis hepatocytes)
	< 33%(groupI)	33%-66%(group II)	> 66%(group III)
n	24	35	25
BMI	28 kg/m2	30 kg/m2	32 kg/m2
Cholesterol (mmol/L) Trigliceryde (mmol/L)	5.50 ± 0.75 2.60 ± 1.27	5.99 ± 1.29 2.78 ± 1.44	6.80 ± 2.30 3.16 ± 1.11
Bilirubina (µmol/L)	11.97 ± 5.13bd	17.1 ± 6.84	27.36 ± 20.52
ALT (μkat/L)	0.84 ± 0.35bd	1.70 ± 1.12	1.67 ± 0.38
AST (μkat/L)	0.60 ± 0.33bd	1.19 ± 0.50	1.87 ± 1.80
ALP (μkat/L)	1.12 ± 0.27bd	1.72 ± 0.45	2.10 ± 0.92
GGT (μkat/L)	0.75 ± 0.33bd	2.61 ± 3.42d	5.06 ± 4.34
Total protein (g/L)	7.4 ± 04d	7.0 ± 0.5d	6.4 ± 0.5
Albumin (g/L)	4.5 ± 1.2d	4.0 ± 0.2d	3.4 ± 0.7

^bP < 0.01 vs group II,

^dP < 0.01 vs group III (non-parametrical Student^'s-t test).